Читать «Кето-навигатор» онлайн - страница 169

40. Guemez-Gamboa A, Nguyen LN, Yang H, et al. Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. Nat Genet. 2015 Jul; 47 (7): 809–813.

41. MSC labelled Aker Biomarine krill products are from a sustainable and wellmanager fishery [Internet. Marine Stewardship Counci. 2018 Mar 27. Доступно по ссылке http://www.msc.org/newsroom/news/msc-labelled-aker-biomarine-krillproducts-are-from-a-sustainable-and-well-managed-fishery.

42. Ulven SM, Kirkhus B, Lamglait A, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011 Jan; 46 (1): 37–46.

43. Krill oil. Monograph. Altern Med Rev. 2010 Apr; 15 (1): 84–86.

44. Maki KC, Reeves MS, Farmer M, et al. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 2009 Sep; 29 (9): 609–615.

45. Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr. 2007 Feb; 26 (1): 39–48.

46. Sampalis F, Bunea R, Pelland MF, et al. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev. 2003 May; 8 (2): 171–179.

47. Gamma-linolenic acid (GLA). Monograph. Altern Med Rev. 2004 Mar; 9 (1): 70–78.

48. Там же.

49. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med.1993 Nov 1; 119 (9): 86–873.

50. Zurier RB, Rossetti RG, Jacobson EW, et al. gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum.1996 Nov; 39 (11): 1808–1817.

51. Gamma-linolenic acid (GLA). Monograph. Altern Med Rev. 2004 Mar; 9 (1): 70–78.

52. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with blackcurrant seed oil. Br J Rheumatol. 1994 Sep; 33 (9): 847–852.

53. Melnik BC, Plewig G. Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1? J Am Acad Dermatol. 1989 Sep; 21 (3 Pt 1): 557–563.

54. Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol. 1989 Jul; 121 (1): 75–90.

55. Horrobin DF. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res. 1992; 31 (2): 163–194.

56. Hansen AE. Essential fatty acids and infant nutrition; Borden award address. Pediatrics. 1958 Mar; 21 (3): 494–501.

57. Kruger MC, Coetzer H, de Winter R, et al. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano). 1998 Oct; 10 (5): 385–394.

58. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gammalinolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003 Mar; 22 (2): 97–101.